All Online

1 - 10 of 10 results

Refine

Active filters

Irritable Bowel Syndrome
1 CME CREDIT

Increasing numbers of patients are talking with their health care professionals about specialized diets and testing for allergies and food sensitivities as part of their overall wellness plan. Good diet quality is a well-recognized element of lifestyle medicine, but there is growing confusion among medical professionals and consumers about "good" foods and if they should eliminate certain foods from their diet. This talk will cover several of the popular media approaches to healthy living, including diets like Gluten Free, Whole 30, Ketogenic, as well as relevant data for health-related outcomes for each. The differences between allergic bowel disorders and intolerances will be discussed. Clinical and nutritional counseling tips will be provided.


0.56 CME CREDIT

IBS is a common gastrointestinal disorder characterized by chronic abdominal pain and an abnormal pattern of bowel movements (i.e., diarrhea, constipation or mixed diarrhea and constipation). This session will cover the diagnosis and management of this nebulous condition, including discussion of current guidelines and available and upcoming therapies for IBS.


0.75 CME CREDIT

The faculty will provide an overview and update of irritable bowel syndrome (IBS), including the new Rome IV diagnostic criteria, pathophysiology and pharmacologic and non-pharmacologic treatment approaches. The lecture will review the new Rome multidimensional clinical disease profiles (MDCP), which helps to characterize the unique profile of a FGID patient with a classification of diagnosis, clinical modifiers, psychological symptoms, quality of life, and biomarkers that help to guide treatment.


1.5 CME CREDITS

This activity will provide an evidence-based approach to diagnosing irritable bowel syndrome (IBS) with minimal testing. Diagnostic tests that facilitate a positive diagnosis of IBS and effective approaches for educating patients will be highlighted. The speakers will spotlight diet changes and over-the-counter agents which are helpful first-line therapies. Evidence-based guidelines will identify the most effective and best tolerated prescription agents for IBS and chronic constipation patients.


grey vector of blue and yellow gastrointenstinal tract

This activity provides an update on the diagnostic criteria for functional bowel disorders, including irritable bowel syndrome (IBS). The activity gives information on how to differentiate between IBS and other bowel disorders like microscopic colitis, celiac disease, colorectal cancer, and inflammatory bowel disease. It also discusses lifestyle and dietary interventions for managing IBS and includes a section on non-celiac gluten sensitivity and the FODMAP diet.


0.75 CME CREDIT

Irritable bowel syndrome (IBS) is the most common disorder seen and treated by gastroenterologists. Despite this, many physicians have difficulty making a definitive diagnosis and approximately 75% of the general population with IBS symptoms remains undiagnosed. Part of this stems from the fact that there are currently no diagnostic studies which conclusively confirm IBS. As such, it has been and continues to be considered a diagnosis of exclusion when in reality newer diagnostic criteria and minimal diagnostic testing can lead to a diagnosis with 98-99% accuracy. A better understanding of the underlying pathophysiology of this disorder has also let to more accurate treatment strategies. In this discussion we will dispel many of the myths and misconceptions surrounding this syndrome.


0.5 CME CREDIT

This podcast is a case-based discussion around practical approaches to caring for patients with CIC and IBS-C. The conversation between a PCP and an expert will address the clinical presentation, differential diagnosis, workup, and treatment of CIC and IBS-C.


Irritable Bowel Syndrome (IBS)

Irritable bowel syndrome (IBS) is the most common GI disorder seen in outpatient practice. Most patients with IBS do not receive a positive IBS diagnosis. While the underlying etiology remains unclear and probably multifactorial, there has been considerable progress in the understanding of this disease. This activity will review the recent theories about IBS and discuss them in relation to diagnosis and treatment. Dr. El-Serag will also review the recent medical and psychological treatments available for IBS.


1 CME CREDIT

Irritable bowel syndrome (IBS) is the most common disorder seen and treated by gastroenterologists. Despite this, many physicians have difficulty making a definitive diagnosis and approximately 75% of the general population with IBS symptoms remains undiagnosed. Part of this stems from the fact that there are currently no diagnostic studies which conclusively confirm IBS. As such, it has been and continues to be considered a diagnosis of exclusion when in reality newer diagnostic criteria and minimal diagnostic testing can lead to a diagnosis with 98-99% accuracy. A better understanding of the underlying pathophysiology of this disorder has also let to more accurate treatment strategies. In this discussion we will dispel many of the myths and misconceptions surrounding this syndrome.


0.5 CME CREDIT

This podcast is a case-based discussion around diagnosis and management of chronic diarrhea in the outpatient setting. The conversation between a PCP and an expert will address clinical presentation, differential diagnosis, workup, and treatment of IBS-D.